These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23169603)

  • 1. Birth defects surveillance: an essential public health function for primary prevention and health promotion.
    Kirby RS; Browne ML
    Birth Defects Res A Clin Mol Teratol; 2012 Dec; 94(12):963-4. PubMed ID: 23169603
    [No Abstract]   [Full Text] [Related]  

  • 2. Public health impact of birth defects monitoring systems: national and international efforts.
    Castilla EE; Peters PW
    Birth Defects Orig Artic Ser; 1992; 28(3):27-36. PubMed ID: 1489954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Health promotion in public politics].
    Warnet S
    Rev Infirm; 2014; (203):11. PubMed ID: 26043538
    [No Abstract]   [Full Text] [Related]  

  • 4. Law as a tool in promoting and protecting public health: always in our best interests?
    Martin R
    Public Health; 2007 Nov; 121(11):846-53. PubMed ID: 17825860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter to the editor: Ventricular septal defects and the National Birth Defects Prevention Study.
    Rasmussen SA; Riehle-Colarusso T; Shapira SK; Honein MA; Reefhuis J;
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):66. PubMed ID: 21254361
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology as a guardian of children's health: translating birth defects research into policy.
    Cassell CH; Golden L
    Ann Epidemiol; 2010 Jul; 20(7):493-8. PubMed ID: 20538192
    [No Abstract]   [Full Text] [Related]  

  • 7. Government's role in protecting health and safety.
    Frieden TR
    N Engl J Med; 2013 May; 368(20):1857-9. PubMed ID: 23593978
    [No Abstract]   [Full Text] [Related]  

  • 8. Public health is high on MMA legislative agenda.
    Christensen RG
    Minn Med; 1997 Mar; 80(3):34. PubMed ID: 9090248
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network.
    Lin AE; Forrester MB; Cunniff C; Higgins CA; Anderka M
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):781-6. PubMed ID: 17051528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of family history reports of major birth defects as a public health strategy.
    Romitti PA
    Pediatrics; 2007 Sep; 120 Suppl 2():S71-7. PubMed ID: 17767008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An expanded public health role for birth defects surveillance.
    Correa A; Kirby RS
    Birth Defects Res A Clin Mol Teratol; 2010 Dec; 88(12):1004-7. PubMed ID: 20878911
    [No Abstract]   [Full Text] [Related]  

  • 12. Balancing benefits and harms in public health prevention programmes mandated by governments.
    Oakley GP; Johnston RB
    BMJ; 2004 Jul; 329(7456):41-3; discussion 43-4. PubMed ID: 15231625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collection, use, and protection of population-based birth defects surveillance data in the united states.
    Mai CT; Law DJ; Mason CA; McDowell BD; Meyer RE; Musa D;
    Birth Defects Res A Clin Mol Teratol; 2007 Dec; 79(12):811-4. PubMed ID: 18064713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth defects surveillance, epidemiology, and significance in public health.
    Collins JS; Kirby RS
    Birth Defects Res A Clin Mol Teratol; 2009 Nov; 85(11):873. PubMed ID: 19824058
    [No Abstract]   [Full Text] [Related]  

  • 15. Population perspective on birth defects: from surveillance to epidemiology to public health.
    Kirby RS; Feldkamp M
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):745-6. PubMed ID: 17094133
    [No Abstract]   [Full Text] [Related]  

  • 16. Birth defects surveillance: epidemiology, health services research, public health, and prevention.
    Kirby RS; Browne ML
    Birth Defects Res A Clin Mol Teratol; 2013 Oct; 97(10):617-8. PubMed ID: 24142497
    [No Abstract]   [Full Text] [Related]  

  • 17. Birth defects surveillance, epidemiology, and public health.
    Kirby RS; Collins JS
    Birth Defects Res A Clin Mol Teratol; 2011 Dec; 91(12):985. PubMed ID: 22125267
    [No Abstract]   [Full Text] [Related]  

  • 18. Folic acid and birth defects prevention: a public health success story.
    Meyer RE; Brown AB
    N C Med J; 2004; 65(3):157-8. PubMed ID: 15335010
    [No Abstract]   [Full Text] [Related]  

  • 19. Birth defects research: improving surveillance methods and addressing epidemiologic questions and public health issues.
    Kirby RS; Seaver LH
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):645. PubMed ID: 16240381
    [No Abstract]   [Full Text] [Related]  

  • 20. EUROCAT: 25 years of European surveillance of congenital anomalies.
    Dolk H
    Arch Dis Child Fetal Neonatal Ed; 2005 Sep; 90(5):F355-8. PubMed ID: 16113149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.